Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod
The VP1 subunit of JC polyomavirus recapitulates early events in viral trafficking and is a novel tool to study polyomavirus entry.
Early signs of memory impairment among multiple sclerosis patients with clinically isolated syndrome.
Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
MRI in multiple sclerosis: an intra-individual, randomized and multicentric comparison of gadobutrol with gadoterate meglumine at 3 T.
Protective Associations of HDL with Blood Brain Barrier Injury in Multiple Sclerosis Patients.
Plasma exchange in severe attacks of neuromyelitis optica.
[Vitamin D for prevention of diseases?].
A qualitative exploration of the impact of a 12-week group exercise class for those moderately affected with multiple sclerosis.
[Controlled research on multiple sclerosis treated with electroacupuncture and acupoint injection].
Modulation of Sox10, HIF-1α, Survivin, and YAP by Minocycline in the Treatment of Neurodevelopmental Handicaps following Hypoxic Insult.
Solodyn
Mesenchymal stem cells as treatment for MS - progress to date.
Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma.
Changes in Cognitive Processing Speed, Mood, and Fatigue in an Observational Study of Persons With Multiple Sclerosis Treated With Dalfampridine-ER.
An Intricate Mechanism of Action of Avonex in Relapsing Remitting Multiple Sclerosis Patients: Variation of Serum Titre of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-β.
Ocrelizumab in multiple sclerosis: risks and benefits.
Multiple sclerosis treatment: current best practice.
Gray matter is targeted in first-attack multiple sclerosis.
Differential diagnosis for cervical spondylotic myelopathy: literature review.
The mammalian Na+/H+ exchanger gene family--initial structure/function studies.
DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).
Molecular targets of FTY720 (fingolimod).
Iron and Non-Iron-Related Characteristics of Multiple Sclerosis and Neuromyelitis Optica Lesions at 7T MRI.
Raltegravir (Isentress) pilot study in relapsing multiple sclerosis (INSPIRE)

Pages